Original Article

Journal of Investigative Dermatology (1978) 70, 51–55; doi:10.1111/1523-1747.ep12543487

THE EFFECT OF ANTIMICROBIAL AGENTS ON LEUKOCYTE CHEMOTAXIS

Nancy B Esterly1,2, Nancy L Furey1,2 and Lillian E Flanagan1,2

  1. 1Division of Dermatology, Department of Pediatrics, Michael Reese Hospital and Medical Center, Chicago, Illinois, U.S.A.
  2. 2Department of Dermatology, Northwestern University School of Medicine, Chicago, Illinois, U.S.A.

Received 5 May 1977; Accepted 29 July 1977.

Top

Abstract

The effects of several chemotherapeutic agents on the chemotaxis of human leukocytes were studied in an in vitro system using a Sykes-Moore chamber and a double-filter technique. Chemotactic factor was generated by the interaction of normal human serum and zymosan. At concentrations comparable to and below therapeutic blood levels, tetracycline HCI, erythromycin base and clindamycin HCI were all inhibitory, causing marked suppression of leukocyte chemotaxis and slight reduction of random migration. Penicillin G-Na, dapsone, and sulfapyridine did not alter white cell motility at the concentrations of drug tested. It is postulated that the capacity of some of these agents to inhibit leukocyte chemotaxis may account, in part, for their efficacy in inflammatory skin diseases such as acne vulgaris.

Top

References

  1. Kligman, AM: An overview of acne. J Invest Dermatol 1974 62: 268–287,  | Article | PubMed | ISI | ChemPort |
  2. Shalita, AR: Genesis of free fatty acids. J Invest Dermatol 1974 62: 332–335,  | Article | PubMed | ChemPort |
  3. Marples, RR: The microflora of the face and acne lesions. J Invest Dermatol 1974 62: 326–331,  | Article | PubMed | ISI | ChemPort |
  4. Kraus, SJ: Reduction in skin surface free fatty acids with topical tetracycline. J Invest Dermatol 1968 51: 431–434,  | PubMed | ChemPort |
  5. Marples, RR, Downing, DT, Kligman, AM: Control of free fatty acids in human surface lipids by Corynebacterium acnes. J Invest Dermatol 1971 56: 127–131,  | Article | PubMed | ISI | ChemPort |
  6. Hassing, GS: Inhibition of Corynebacterium acnes by tetracycline. J Invest Dermatol 1971 56: 189–192,  | Article | PubMed | ChemPort |
  7. Mills, OH, Marples, RR, Kligman, AM: Acne vulgaris oral therapy with tetracycline and topical therapy with vitamin A. Arch Dermatol 1972 106: 200–203,  | Article | PubMed |
  8. Cunliffe, WJ, Coterill, JA, Williamson, B: The effect of clindamycin in acne: A clinical and laboratory investigation. Br J Dermatol 1972 87: 37–41,  | PubMed | ChemPort |
  9. Cunliffe, WJ, Forster, RA, Greenwood, ND, Heatherington, C, Holland, KT, Holmes, RL, Khan, S, Roberts, CD, Williams, M, Williamson, B: Tetracycline and acne vulgaris: A clinical and laboratory investigation. Br Med J 1973 2: 332–335,  | PubMed |
  10. Fulton, JG, Pablo, G: Topical antibacterial therapy for acne: Study of the family of erythromycins. Arch Dermatol 1974 110: 83–86,  | Article | PubMed |
  11. Baer, RL, Leshaw, SM, Shalita, AR: High-dose tetracycline therapy in severe acne. Arch Dermatol 1976 112: 479–481,  | Article | PubMed | ChemPort |
  12. Resh, W, Stoughton, RB: Topically applied antibiotics in acne vulgaris: Clinical response and suppression of Corynebacterium acnes in open comedones. Arch Dermatol 1976 112: 182–184,  | Article | PubMed | ChemPort |
  13. Anderson, RL, Cook, CH, Smith, DH: The effect of oral and topical tetracycline on acne severity and on surface lipid composition. J Invest Dermatol 1976 66: 172–177,  | Article | PubMed | ChemPort |
  14. Martin, RR, Warr, GA, Couch, RB, Yeager, H, Knight, V: Effects of tetracycline on leukotaxis. J Infect Dis 1974 129: 110–116,  | PubMed | ChemPort |
  15. Plewig, G, Schöpf, E: Anti-inflammatory effects of antimicrobial agents: An in vivo study. J Invest Dermatol 1975 65: 532–536,  | Article | PubMed | ChemPort |
  16. Kuntson, DD: Ultrastructural observations in acne vulgaris: The normal sebaceous follicle and acne lesions. J. Invest Dermatol 1974 62: 288–307,  | PubMed |
  17. Comely, HP: Reversal of chemotaxis in vitro and chemotactic activity of leukocyte fractions. Proc Soc Exp Biol Med 1966 122: 831–835,  | PubMed |
  18. Baum, J, Mowat, AG, Kirk, JA: A simplified method for the measurement of chemotaxis of polymorphonuclear leukocytes from human blood. J Lab Clin Med 1971 77: 501–509,  | PubMed | ChemPort |
  19. Warden, GD, Mason, AD Jr, Pruitt, BA Jr: Suppression of leukocyte chemotaxis in vitro by chemotherapeutic agents used in the management of thermal injuries. Ann Surg 1975 181: 363–369,  | PubMed | ChemPort |
  20. Keller, HV, Borel, JF, Wilkinson, PC, Hess, MW, Cottier, H: Reassessment of Boyden's technique for measuring chemotaxis. J Immunol Meth 1972 1: 165–168,  | Article | ChemPort |
  21. Keller, HV, Hess, MW, Cottier, H: Physiology of chemotaxis and random motility. Semin Hematol 1975 12: 47–57,  | PubMed | ChemPort |
  22. Ward, PA: The chemosuppression of chemotaxis. J Exp Med 1966 124: 209–226,  | Article | PubMed | ChemPort |
  23. Martin, RR, Warr, G, Couch, R, Knight, V: Chemotaxis of human leukocytes: Responsiveness to Mycoplasma pneumoniae. J Lab Clin Med 1973 81: 520–529,  | PubMed | ChemPort |
  24. Goetzl, EJ, Wasserman, SI, Gigli, I, Austen, KF: Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid. J Clin Invest 1974 53: 813–818,  | PubMed | ChemPort |
  25. Lorincz, AL, Pearson, RW: Sulfapyridine and sulfone type drugs in dermatology. Arch Dermatol 1962 85: 42–56,
  26. Alexander, JO'd, Young, E, McFadyen, T, Fraser, NG, Duguid, WP, Meredith, EM: Absorption and excretion of 35S dapsone in dermatitis herpetiformis. Br J Dermatol 1970 83: 620–631,  | PubMed | ChemPort |
  27. Mier, PD, Van Den Hurk, JMA: Inhibition of lysosomal enzymes by dapsone. Br J Dermatol 1975 93: 471–472,  | PubMed | ChemPort |
  28. Barranco, VP: Inhibition of lysosomal enzymes by dapsone. Arch Dermatol 1974 110: 563–566,  | Article | PubMed | ChemPort |
  29. Thompson, DM, Souhami, R: Suppression of the Arthus reaction in the guinea pig by dapsone. Proc R Soc Med 1975 68: 273,  | PubMed | ChemPort |
  30. Provost, TT, Tomasi, TB Jr: Evidence for the activation of complement via the alternate pathway in skin disease: II. Dermatitis herpetiformis. Clin Immunol Immunopathol 1974 3: 178–186,  | Article | PubMed | ChemPort |
  31. Katz, SI, Hertz, KG, Crawford, PS, Gazze, LA, Frank, MM, Lawley, PJ: The effect of sulfones on complement deposition in dermatitis herpetiformis and on complement-mediated guinea pig reactions. J Invest Dermatol 1976 67: 688–690,  | Article | PubMed | ChemPort |

Extra navigation

.
ADVERTISEMENT